Related Experiment Video

Updated: Jul 17, 2026

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
11:08

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling

Published on: February 5, 2018

Rational design and synthesis of novel nucleotide anti-Giardia agents

Dae-Hwan Suk1, Laurent Bonnac, Christine C Dykstra

  • 1Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, MN 55455, USA.

Bioorganic & Medicinal Chemistry Letters
|January 30, 2007
PubMed

Abstract:

Design and synthesis of a novel nucleotide anti-Giardia agent that is micromolar inhibitor of Giardia trophozoite growth in culture is described.

More Related Videos

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)

Published on: September 17, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jul 17, 2026

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
11:08

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling

Published on: February 5, 2018

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)

Published on: September 17, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...

Articles linked to this work by shared authors, journal, and citation graph.

Synthesis and evaluation of anti-Giardia activity of oseltamivir analogs.

Bioorganic & medicinal chemistry letters·2024

Giardial lipid rafts share virulence factors with secreted vesicles and participate in parasitic infection in mice.

Frontiers in cellular and infection microbiology·2022

Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen.

Journal of molecular biology·2021

Triazoxins: Novel nucleosides with anti-Giardia activity.

Bioorganic & medicinal chemistry letters·2020

Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.

Antiviral research·2019

Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients.

Transplantation·2019

Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells.

Bioorganic & medicinal chemistry letters·2026

Quinolin(on)es and pyridin(on)es as promising scaffolds against mycobacterial infections.

Bioorganic & medicinal chemistry letters·2026

Amyloid-β aggregation inhibitory activity and neuroprotective effects of metabolites of Trichoderma pluripenicillatum.

Bioorganic & medicinal chemistry letters·2026

Electrophilic aromatic halogenation of perylenequinones: a strategy to improve photodynamic properties.

Bioorganic & medicinal chemistry letters·2026

Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.

Bioorganic & medicinal chemistry letters·2026

6-(2-Hydroxybenzoyl)pyrazolo[1,5-a]pyrimidine-3‑carbonitriles as novel reactive oxygen species-generating anticancer agents inducing ER stress and DNA damage in EGFR-mutant non-small cell lung cancer.

Bioorganic & medicinal chemistry letters·2026

VCCV: conservative transcriptomic corroboration for measurement prioritization of computational drug-target hypotheses.

Bioinformatics (Oxford, England)·2026

Redirecting MurD inhibitor preference toward MurD2 through glutamate stereochemical inversion.

Bioorganic & medicinal chemistry·2026

High potency μ-opioid receptor agonists engage sodium-bound receptor states.

Molecular pharmacology·2026

Druggable secondary sites in C-type lectin-like domains: Mechanistic insights and opportunities for chemical modulation.

Current opinion in chemical biology·2026

Integrative AI-assisted modeling suggests CPPF binding at a composite [Formula: see text]/[Formula: see text]-tubulin interface pocket dominated by [Formula: see text]-tubulin contacts.

PLoS computational biology·2026

Linear antibody epitope prediction using AlphaFold2.

eLife·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us